Skip to content

Salt-substitute After-intervention Follow-up and long-term Effect study SAFE study

Salt-substitute After-intervention Follow-up and long-term Effect study SAFE study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600128043
Enrollment
Unknown
Registered
2026-07-13
Start date
2026-07-14
Completion date
Unknown
Last updated
2026-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric cancer

Interventions

The observation group that previously received low-sodium salt intervention:None

Sponsors

The Second Affiliated Hospital of Harbin Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 100 Years

Inclusion criteria

Inclusion criteria: 1.All participants in previous studies;

Exclusion criteria

Exclusion criteria: 1.None;

Design outcomes

Primary

MeasureTime frame
Incidence of kidney-related outcomes;Incidence of major adverse cardiovascular events;Incidence of gastric cancer-related outcomes;

Secondary

MeasureTime frame
Incidence of all cancer-related outcomes;Incidence of gastrointestinal cancer-related outcomes;Incidence of hyperkalaemia;Incidence of hypokalaemia;All-cause mortality;

Countries

China

Contacts

Public ContactTian Maoyi

The Second Affiliated Hospital of Harbin Medical University

maoyi.tian@hrbmu.edu.cn+86 451 86605411

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 23, 2026